FDA Inspection 630768 — Qingdao Jiulong Biopharmaceutical Co. Ltd.
The FDA completed an inspection of Qingdao Jiulong Biopharmaceutical Co. Ltd. on November 23, 2009 in Qingdao. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 23, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Qingdao (China)